XML 62 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity - Activity Related to Stock Option Plans (Details)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Shares available for grant, beginning balance (in shares) 8,699,941
Options outstanding, number of shares, beginning balance (in shares) 20,479,278
Options outstanding, number of shares granted (in shares) 1,850,795
Options outstanding, number of shares, exercised (in shares) (1,652,692)
Options outstanding, number of shares expired (in shares) (175)
Shares available for grant, ending balance (in shares) 6,849,146
Options outstanding, number of shares, ending balance (in shares) 20,677,206
Options vested and exercisable, number of shares, ending balance (in shares) 20,677,206
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Options outstanding, weighted-average exercise price, beginning balance (dollars per share) | $ / shares $ 89.61
Options outstanding, weighted-average exercise price, granted (dollars per share) | $ / shares 333.73
Options outstanding, weighted-average exercise price, exercised (dollars per share) | $ / shares 34.29
Options expired, weighted-average exercise price (dollars per share) | $ / shares 6.17
Options outstanding, weighted-average exercise price, ending balance (dollars per share) | $ / shares 115.88
Options outstanding, weighted-average exercise price, vested and exercisable (dollars per share) | $ / shares $ 115.88
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Weighted-average remaining contractual term, ending balance (in years) 5 years 6 months 25 days
Weighted-average remaining contractual term, vested and exercisable (in years) 5 years 6 months 25 days
Aggregate intrinsic value, ending balance | $ $ 3,361,640
Aggregate intrinsic value, vested and exercisable | $ $ 3,361,640